Apollo Invests €3 Billion in Bayer’s Long-Acting Reversible Contraceptives Business, KKR Joins
Global investment firm Apollo has finalized a significant €3 billion investment in Bayer’s dedicated business unit focused on long-acting reversible contraceptives (LARCs). The landmark deal, which also sees KKR participating,…
